Symbol |
Name |
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
ADRA1B
|
adrenoceptor alpha 1B
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
CKB
|
creatine kinase, brain
|
CLOCK
|
clock circadian regulator
|
CNR1
|
cannabinoid receptor 1 (brain)
|
DISC1
|
disrupted in schizophrenia 1
|
DRD3
|
dopamine receptor D3
|
ERC2
|
ELKS/RAB6-interacting/CAST family member 2
|
EYA3
|
EYA transcriptional coactivator and phosphatase 3
|
FMR1
|
fragile X mental retardation 1
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
HTR5A
|
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
|
HTT
|
huntingtin
|
LSAMP
|
limbic system-associated membrane protein
|
NPAS3
|
neuronal PAS domain protein 3
|
OPHN1
|
oligophrenin 1
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
PDE1B
|
phosphodiesterase 1B, calmodulin-dependent
|
PFN2
|
profilin 2
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
PTPRF
|
protein tyrosine phosphatase, receptor type, F
|
S100A1
|
S100 calcium binding protein A1
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
|